Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health.

Schwalfenberg GK.

J Nutr Metab. 2017;2017:6254836. doi: 10.1155/2017/6254836. Epub 2017 Jun 18. Review.

2.

Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE.

J Thromb Thrombolysis. 2016 Jan;41(1):187-205. doi: 10.1007/s11239-015-1319-y. Review.

3.

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.

Douxfils J, Tamigniau A, Chatelain B, Goffinet C, Dogné JM, Mullier F.

Thromb J. 2014 Nov 4;12:24. doi: 10.1186/1477-9560-12-24. eCollection 2014. Review.

4.

Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.

Mearns ES, White CM, Kohn CG, Hawthorne J, Song JS, Meng J, Schein JR, Raut MK, Coleman CI.

Thromb J. 2014 Jun 24;12:14. doi: 10.1186/1477-9560-12-14. eCollection 2014.

5.

Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.

Mearns ES, Hawthorne J, Song JS, Coleman CI.

BMJ Open. 2014 Jun 20;4(6):e005379. doi: 10.1136/bmjopen-2014-005379. Review.

6.

Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11.

Edson KZ, Prasad B, Unadkat JD, Suhara Y, Okano T, Guengerich FP, Rettie AE.

Biochemistry. 2013 Nov 19;52(46):8276-85. doi: 10.1021/bi401208m. Epub 2013 Nov 7.

7.

Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: a prospective cohort study.

Li RC, Finkelman BS, Chen J, Booth SL, Bershaw L, Brensinger C, Kimmel SE.

Thromb Haemost. 2013 Jul;110(1):195-6. doi: 10.1160/TH13-02-0111. Epub 2013 Mar 21. No abstract available.

8.

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G.

Chest. 2012 Feb;141(2 Suppl):e44S-e88S. doi: 10.1378/chest.11-2292. Review.

9.

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH.

Chest. 2012 Feb;141(2 Suppl):e152S-e184S. doi: 10.1378/chest.11-2295. Review.

10.

Supplemental vitamin K improves the stability of anticoagulation in a patient with low tissue stores of vitamin K secondary to coeliac disease.

Janeczko CE, Sweeney K, Connaghan G.

BMJ Case Rep. 2009;2009. pii: bcr10.2008.1067. doi: 10.1136/bcr.10.2008.1067. Epub 2009 May 17.

11.

Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study.

Gebuis EP, Rosendaal FR, van Meegen E, van der Meer FJ.

Haematologica. 2011 Apr;96(4):583-9. doi: 10.3324/haematol.2010.035162. Epub 2010 Dec 29.

12.

Warfarin and vitamin K intake in the era of pharmacogenetics.

Lurie Y, Loebstein R, Kurnik D, Almog S, Halkin H.

Br J Clin Pharmacol. 2010 Aug;70(2):164-70. doi: 10.1111/j.1365-2125.2010.03672.x. Review.

13.

Effectiveness of warfarin among patients with cancer.

Rose AJ, Sharman JP, Ozonoff A, Henault LE, Hylek EM.

J Gen Intern Med. 2007 Jul;22(7):997-1002. Epub 2007 May 3.

Supplemental Content

Support Center